Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.

GLP-1 mimetics and diabetic ketoacidosis: possible interactions and clinical consequences

Abstract

Diabetic ketoacidosis is a serious diabetes-related consequence that occurs in type 1 diabetes and less commonly in type 2 diabetes and is a major cause of death. It results from the metabolic consequences due to a lack of insulin secretion or impaired insulin activity in diabetes leading to dysregulated pathophysiologic pathways resulting in excessive ketone body formation. While ketone bodies are physiologic molecules, their high levels reduce the physiological pH of the blood and induce ketoacidosis, leading to increasing metabolic dysfunction. Glucagon-like peptide-1 (GLP-1) mimetics are a class of recently developed diabetes therapy that do not lead to hypoglycemic, but some reports have suggested a relationship between GLP-1 mimetics and ketogenesis. To clarify the possible interactions between GLP-1 mimetics and ketogenesis in diabetes, this review was undertaken to collate and interpret the literature.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00210-024-03384-1

Cites

113 of 113 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 113 references

Research works printed but not linked: 3

  1. Balaji R, Duraisamy R, Kumar M (2019) Complications of diabetes mellitus: a review. Drug Invent Today 12(1)
  2. Caballero B, Trugo L, Finglas P (2003) Encyclopedia of food sciences and nutrition: Volumes 1–10: Elsevier Science BV
  3. Collins L, Costello R (2020) Glucagon-like peptide-1 receptor agonists. StatPearls. StatPearls Publishing. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK551568/. Accessed 17 Aug 2024

Cited by

See all 3

Metadata

Authors
Forouzanmehr, B., Hemmati, M. A., Atkin, S. L., Jamialahmadi, T., Yaribeygi, H., & Sahebkar, A.
Affiliations
  • Semnan University of Medical Sciences (IR)
  • Royal College of Surgeons in Ireland - Bahrain (BH)
  • Mashhad University of Medical Sciences (IR)
Corresponding author
  • Yaribeygi, Habib
  • Sahebkar, Amirhossein
Venue
Naunyn-Schmiedeberg's Archives of Pharmacology
Published
2024-08-22
Volume
398
Issue
1
Pages
351-362
ISSN
  • 0028-1298 (ISSN-L)
  • 1432-1912
OpenAlex
W4401793502
Cited by
3
References
113
Citations by year
2026: 3
FWCI
0.18
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Naunyn-Schmiedeberg s Archives of Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
Keywords
GLP-1 receptor agonists, diabetic ketoacidosis, ketogenesis, ketone bodies, type 1 diabetes, type 2 diabetes, insulin deficiency, drug interactions, metabolic dysfunction
MeSH terms
Animals, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Ketone Bodies, Diabetic Ketoacidosis, Glucagon-Like Peptide 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: GLP-1 mimetics and diabetic ketoacidosis: possible interactions and clinical consequences. https://app.cochat.ai/papers/10.1007/s00210-024-03384-1
The paper
Forouzanmehr, B., Hemmati, M. A., Atkin, S. L., Jamialahmadi, T., Yaribeygi, H., & Sahebkar, A. (2025). GLP-1 mimetics and diabetic ketoacidosis: possible interactions and clinical consequences. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03384-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.